The US Food and Drug Administration issued national priority vouchers to companies studying psilocybin and methylone for the treatment of some mental health disorders. The vouchers were granted under Emerging And Approved Therapeutic Peptides: Mechanisms, Clinical Uses GlobalRPH FDA Approved Drug List! MedChemExpress October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York